Related Experiment Video
Updated: Sep 11, 2025

05:22
Author Spotlight: Enhanced Multiplex Immunofluorescent Microscopy Protocol for Neuroscience Research
Published on: June 21, 2024
523
ROSIE: AI generation of multiplex immunofluorescence staining from histopathology images.
Eric Wu1,2, Matthew Bieniosek3, Zhenqin Wu3
1Enable Medicine, Menlo Park, CA, USA. wue@stanford.edu.
Nature Communications
|August 16, 2025
Summary
ROSIE, a deep learning framework, computationally predicts protein expression from H&E images. This in silico multiplex immunofluorescence method aids in identifying cell phenotypes and tumor-infiltrating lymphocytes for cancer research.
Area of Science:
- Computational pathology
- Biomarker discovery
- Artificial intelligence in medicine
Background:
- Hematoxylin and eosin (H&E) staining is a fundamental histopathology technique.
- H&E lacks direct molecular marker information, necessitating further assays.
- Identifying specific cell types and microenvironments is crucial for disease understanding.
Purpose of the Study:
- To introduce ROSIE, a deep learning framework for imputing protein expression and localization from H&E images.
- To enable in silico multiplex immunofluorescence (mIF) analysis.
- To enhance the diagnostic and prognostic capabilities of routine histopathology.
Main Methods:
- Training a deep learning model on over 1300 paired H&E and mIF samples across diverse tissues and diseases.
- Utilizing a dataset spanning over 16 million cells for robust model development.
- Validating the imputation accuracy on held-out H&E samples.
Main Results:
- ROSIE accurately predicts the expression and localization of numerous proteins from H&E images.
- In silico mIF effectively distinguishes cell phenotypes, including lymphocytes (B cells, T cells).
- The framework robustly identifies stromal, epithelial microenvironments, and tumor-infiltrating lymphocytes (TILs).
Conclusions:
- ROSIE bridges the gap between H&E morphology and molecular information.
- The computational approach aids in understanding tumor-immune interactions and cancer progression.
- This AI-driven tool can inform novel treatment strategies and improve cancer diagnostics.

